Sort
82,697 grants matching “vaccine development”
Basic Research Support for the CCR
$873,318Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Guiding the maturation of anti-CD4-BS bnAbs through sequential heterologous Env immunization
$873,050Leonidas A Stamatatos · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
$872,956Sung Hwan Cho · Nanocellect Biomedical, Inc. · R44 · FY2023 · GM
Small Molecule Inhibitors of Ebola Virus Polymerase Function
$872,936Christopher F Basler · Georgia State University · R01 · FY2018 · AI
Molecular Basis of KSHV oncogenesis
$872,907Jae U Jung · Cleveland Clinic Lerner Com-Cwru · R35 · FY2021 · CA
Human Skin Disease Resource-based Center
$872,601Rachael Ann Clark · Brigham And Women'S Hospital · P30 · FY2016 · AR
Development of a Mucosal Nanoemulsion-Adjuvanted RSV Vaccine using Recombinant Pre-Fusion F Protein
$872,585Kevin Trabbic · Bluewillow Biologics, Inc. · R44 · FY2023 · AI
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
$872,522Bryan Briney · Scripps Research Institute, The · R01 · FY2024 · AI
Live Attenuated Bacterial Vaccines Against Plaque
$872,509James E Galen · University Of Maryland Baltimore · U01 · FY2011 · AI
Determinants of retroviral replication in non-native hosts for modeling HIV infection
$872,509Amit Sharma · Ohio State University · R01 · FY2023 · AI
ADOLESCENT MEDICINE TRIALS UNIT
$872,469Donna Futterman · Albert Einstein College Of Medicine · U01 · FY2012 · HD
Molecular Pathogenesis of Neoplasia
$872,468John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Risk of Neonatal Vaccination for HIV/SIV Exposed Infants
$872,386Donald L Sodora · Seattle Biomedical Research Institute · R01 · FY2014 · DE
Immuno-Targeted Therapy for Melanoma
$872,264Antoni Ribas · University Of California Los Angeles · R35 · FY2019 · CA
Role of inflammation, innate resistance, and immunity in carcinogenesis.
$872,235Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Task A11: SMALL ANIMAL MODELS FOR BIODEFENSE VIRUSES
$872,225John Morrey · Utah State University · N01 · FY2018 · AI
Structure-Based Design of a Broadly Protective Group A Streptococcal Vaccine
$872,121James B. Dale · University Of Tennessee Health Sci Ctr · R01 · FY2019 · AI
Drug Repurposing Screening for Zika Virus Infection
$872,090Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
The Immunobiology of Marrow Allografts for Leukemia
$872,075Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$872,044Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2020 · AI
Novel Therapeutics for Neurotropic Alphaviruses
$872,005David J Miller · University Of Michigan At Ann Arbor · R01 · FY2013 · AI
Functional Biology Of T Cells
$872,004Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Antigenicity and Immunogenicity of Stabilized prefusion F protein
$871,866Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Studying factors controlling cancer progression and immune recognition in mouse models
$871,800Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2022 · CA
Novel Adjuvant Discovery in Vaccine Therapy
$871,728Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2012 · AI